Carregant...
Oral Delivery of Metformin by Chitosan Nanoparticles for Polycystic Kidney Disease
Nanoparticle drug delivery has many advantages over small molecule therapeutics, including reducing off-target side effects and increasing drug potency. However, many nanoparticles are administered parenterally, which is challenging for chronic diseases such as polycystic kidney disease (PKD), the m...
Guardat en:
| Publicat a: | J Control Release |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7904655/ https://ncbi.nlm.nih.gov/pubmed/33127449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.10.047 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|